ARCHIVES

NCAB Hears “Impressive” Progress Reports, Including Treatment for Breast, Liver Cancer, Vaccine Studies

This article is from The Cancer Letter archive.

Vol. 01 No. 37 | October 18, 1974

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

New P01 Guidelines Will Go Into Effect Feb. 1 Not Oct. 1

September 16, 1983

Cuts From NCI Budget total $38 Million; Prevention Gets $21 Million Increase

January 24, 1992

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

August 2, 1985

Guidelines Published On Lung Cancer Treatment

February 28, 2003

NCAB Removes Its Restrictions On PDQ Access, Permits NCI Staff To Decide

February 7, 1986